ALLIANCEBERNSTEIN L.P. - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 131 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$2,026,000
+60.3%
107,4000.0%0.00%0.0%
Q2 2019$1,264,000
-10.4%
107,400
+3.9%
0.00%0.0%
Q1 2019$1,411,000
-45.7%
103,400
-59.2%
0.00%
-50.0%
Q4 2018$2,597,000
+50.8%
253,400
+145.1%
0.00%
+100.0%
Q3 2018$1,722,000
+5.4%
103,4000.0%0.00%0.0%
Q2 2018$1,634,000
+51.2%
103,400
+21.5%
0.00%0.0%
Q1 2018$1,081,000
-48.3%
85,106
-53.4%
0.00%0.0%
Q4 2017$2,092,000
+158.3%
182,740
+176.3%
0.00%0.0%
Q3 2017$810,000
-95.2%
66,140
-95.5%
0.00%
-92.3%
Q2 2017$16,930,000
-43.1%
1,478,616
+3.4%
0.01%
-45.8%
Q1 2017$29,740,000
-7.7%
1,429,799
-7.7%
0.02%
-11.1%
Q4 2016$32,228,000
-25.9%
1,549,442
+16.7%
0.03%
-27.0%
Q3 2016$43,504,000
+27.3%
1,327,562
-3.0%
0.04%
+27.6%
Q2 2016$34,177,000
-12.4%
1,368,718
-14.1%
0.03%
-12.1%
Q1 2016$39,010,000
-20.0%
1,592,907
+7.8%
0.03%
-21.4%
Q4 2015$48,790,000
+0.6%
1,477,129
-0.2%
0.04%0.0%
Q3 2015$48,502,000
-30.6%
1,480,526
+12.2%
0.04%
-27.6%
Q2 2015$69,926,000
+82.9%
1,320,109
-0.3%
0.06%
+87.1%
Q1 2015$38,222,000
+33724.8%
1,324,381
+33858.5%
0.03%
Q4 2014$113,000
+71.2%
3,900
-25.0%
0.00%
Q3 2014$66,000
-47.6%
5,200
-17.5%
0.00%
Q2 2014$126,0006,3000.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders